Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.14 USD | -0.33% | +7.97% | -35.29% |
Jun. 04 | Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses | CI |
May. 09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Transcripts